Allworth Financial’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.4K Buy
1,447
+1,349
+1,377% +$48.6K ﹤0.01% 2539
2026
Q1
$3.47K Buy
98
+63
+180% +$2.56K ﹤0.01% 4149
2025
Q4
$1.42K Sell
35
-7
-17% -$305 ﹤0.01% 4247
2025
Q3
$1.98K Buy
42
+33
+367% +$1.71K ﹤0.01% 4005
2025
Q2
$469 Sell
9
-4
-31% -$220 ﹤0.01% 4153
2025
Q1
$663 Buy
13
+8
+160% +$516 ﹤0.01% 3607
2024
Q4
$355 Sell
5
-40
-89% -$2.79K ﹤0.01% 3676
2024
Q3
$3.24K Sell
45
-16
-26% -$1.13K ﹤0.01% 2756
2024
Q2
$4.33K Buy
61
+56
+1,120% +$4.08K ﹤0.01% 2582
2024
Q1
$401 Sell
5
-13
-72% -$1.16K ﹤0.01% 3338
2023
Q4
$1.97K Buy
18
+13
+260% +$1.34K ﹤0.01% 2690
2023
Q3
$505 Buy
5
+3
+150% +$345 ﹤0.01% 3044
2023
Q2
$272 Buy
+2
New +$244 ﹤0.01% 3039
2022
Q4
Sell
-2
Closed 3045
2022
Q3
$0 Buy
+2
New +$189 ﹤0.01% 2718
2022
Q2
Sell
-2
Closed 2452
2022
Q1
$0 Buy
+2
New +$279 ﹤0.01% 2151

Other funds holding CNMD

Allworth Financial's CNMD Position: Q2 2026 in Review

Allworth Financial increased its CONMED (CNMD) stake by 1,377% in Q2 2026, buying an estimated $48.6K and bringing the position to 1,447 shares worth $47.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Allworth Financial first reported a position in CNMD in Q1 2022 and has held it in 15 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Allworth Financial held 1,447 shares of CONMED worth $47.4K as of Q2 2026.
  • Allworth Financial bought 1,349 CONMED shares in Q2 2026, an estimated $48.6K.
  • CONMED made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2539 holding.
  • Allworth Financial first reported a position in CONMED in Q1 2022 and has held it in 15 quarters since.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.